13D/13G Filings - Kura Oncology Inc. (KURA)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-02-11
4:59 pm
Sale
2020-12-3113GKura Oncology, Inc.
KURA
BIOTECHNOLOGY VALUE FUND L P1,245,912
1.900%
-1,188,784decrease
(-48.83%)
Filing
History
2021-02-08
10:27 am
Purchase
2021-02-0513GKura Oncology, Inc.
KURA
FMR LLC9,116,040
13.821%
2,318,838increase
(+34.11%)
Filing
History
2021-02-03
2:29 pm
Sale
2020-12-3113GKura Oncology, Inc.
KURA
Victory Capital Management, Inc.1,836,141
2.780%
-538,445decrease
(-22.68%)
Filing
History
2021-01-29
5:23 pm
Purchase
2020-12-3113GKura Oncology, Inc.
KURA
BlackRock Inc.
BLK
4,931,956
7.600%
1,938,204increase
(+64.74%)
Filing
History
2021-01-28
4:41 pm
Sale
2020-12-3113GKura Oncology, Inc.
KURA
WILSON TROY EDWARD2,190,379
3.300%
-462,076decrease
(-17.42%)
Filing
History
Goto Prev, 0, 1, 2